A multicentre, cluster randomised, double cross over pragmatic clinical trial comparing the safety and efficacy of enteral olanzapine with quetiapine in critically ill patients with hyperactive delirium (CALM-ICU). (ACTRN12622001532796)
CALM-ICU
This study is no longer recruiting patients. The following details are for information only.
This trial is Recently completed/closed
Registration number ACTRN12622001532796
Program & service
This trial is being run with the Intensive Care Services service, and as part of the Intensive Care program.
Trial phase
Other
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Andrew Udy
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.